CAS: 1286739-19-2 - 6-(2-Chloro-4-thiazol-5-yl-phenyl)-8-ethyl-2-[4-(4-Methyl-piperazin-1-yl)-phenylamino]-8H-pyrido[2,3-d]pyrimidin-7-one
- Sinónimos:
- Frax597
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-[2-chloro-4-(5-thiazolyl)phenyl]-8-ethyl-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]- REF: IN-DA000YA0CAS: 1286739-19-2 | % | A consultar | Mar 21 Ene 25 | |
FRAX597 REF: TM-T6014CAS: 1286739-19-2 | 97.34% - 99.85% | 40,00 €~1.243,00 € | Mar 28 Ene 25 | |
FRAX 597 REF: TR-F763805CAS: 1286739-19-2 | - - - | 278,00 € | Lun 03 Mar 25 | |
FRAX597 REF: 3D-FF137673CAS: 1286739-19-2 | Min. 95% | - - - | Producto descatalogado |
Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-[2-chloro-4-(5-thiazolyl)phenyl]-8-ethyl-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-
CAS:1286739-19-2
Fórmula:
C29H28ClN7OS
Pureza:
%
Forma y color:
Solid
Peso molecular:
558.0969
Ref: IN-DA000YA0
2mg | 64,00 € | ||
5mg | 99,00 € | ||
10mg | 134,00 € | ||
25mg | 191,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
FRAX597
CAS:1286739-19-2
FRAX597 is an effective, ATP-competitive inhibitor of group I PAKs, and for PAK1(IC50=8 nM), PAK2(IC50=13 …
Fórmula:
C29H28ClN7OS
Pureza:
97.34% - 99.85%
Forma y color:
Solid
Peso molecular:
558.1
Ref: TM-T6014
1mg | 40,00 € | ||
2mg | 52,00 € | ||
5mg | 86,00 € | ||
10mg | 134,00 € | ||
25mg | 235,00 € | ||
50mg | 387,00 € | ||
100mg | 579,00 € | ||
500mg | 1.243,00 € |
Entrega estimada en Estados Unidos, el Martes 28 de Enero de 2025
FRAX 597
Producto controladoCAS:1286739-19-2
Fórmula:
C29H28ClN7OS
Forma y color:
Neat
Peso molecular:
558.1
Ref: TR-F763805
2500µg | 278,00 € |
Entrega estimada en Estados Unidos, el Lunes 3 de Marzo de 2025
FRAX597
CAS:1286739-19-2
FRAX597 is an effector protein that belongs to the group of TNF-α. It has been …
Pureza:
Min. 95%
Ref: 3D-FF137673
5mg | Descatalogado | Solicitar información | |
10mg | Descatalogado | Solicitar información | |
25mg | Descatalogado | Solicitar información |